BNF:

3.11

Status:

Red

Decision Date:

May 2013

Comments

RED:^1,2,3 NICE TA 504 (replaces NICE TA282): for treating idiopathic pulmonary fibrosis (Decision date- March 2018)

NHS England drug. To be used in line with NHS England commissioning intentions

 

Risk of serious live injury and updated advice on liver function testing (MHRA November 2020)

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
• 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
• 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again